Skip to main content
Premium Trial:

Request an Annual Quote

Novigenix-Led Consortium Awarded Up to €1M to Develop Predictive Immune Checkpoint Inhibitor Test

NEW YORK — A research consortium led by Novigenix has received a Eurostars grant worth up to €1 million ($1.2 million) to develop a blood-based test to predict cancer patient responses to immune checkpoint inhibitors (ICIs), the Swiss molecular diagnostics firm said on Tuesday.

According to Novigenix, the consortium — which includes PamGene International and Radboud University — has already generated data predicting metastatic urothelial cancer patients' responses to anti-PD-1 checkpoint inhibitors.

The group will build off this work using use mRNA and kinase activity profiling to identify multi-omic predictive signatures for ICI response with Novigenix contributing its expertise in immuno-transcriptomics and artificial intelligence, PamGene providing kinome technology, and Radboud University researchers leading a clinical network for the prospective collection of biological specimens and data interpretation.

In January, Novigenix and collaborators were awarded up to €1 million from Eurostars, which is funded by European governments and the European Union, to develop a blood-based multi-omics colorectal cancer assay.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.